Skip to content

The DAPE study: the impact of dementia advisors on the quality of life of dementia sufferers

A randomised controlled trial to assess the impact that dementia advisors have on the quality of life of people with dementia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33790007
Enrollment
700
Registered
2009-10-14
Start date
2009-09-15
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Mental and Behavioural Disorders Unspecified dementia

Interventions

As of 09/02/2010 the status of this record was updated as this trial never started due to pragmatic difficulties combining the delivery service and the research assessments. The aim of the DAPE trial
1. The Dementia Advisor Service 2. Information only Therefore all participants at a particular site will receive either 1 or 2 depending of which one they have been allocated to. The randomisation wi

Sponsors

King's College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals with a diagnosis of dementia made by their primary care physician or a specialist clinician (no age range although most participants will be over 60 years, either sex) 2. Individuals referred for a specialist assessment with a likely diagnosis of dementia 3. Individuals referred to the Dementia Advisor Programme

Exclusion criteria

Exclusion criteria: 1. Individuals who do not have significant cognitive impairment 2. Individuals with a diagnosis of mild cognitive impairment given by either their primary care physician or specialist clinician 3. Individuals who are not likely to receive a diagnosis of dementia within the next 6 months

Design outcomes

Primary

MeasureTime frame
Dementia Quality of Life (DEMQOL), which is considered the most sensitive measure currently available to measure quality of life in people with dementia. Assessments will be done at baseline and 12 months.

Secondary

MeasureTime frame
Assessments will be done at baseline and 12 months: 1. The Quality of Life in Alzheimer's Disease (QOL-AD) 2. The Cornell Scale for Depression in Dementia (CSDD) 3. General Health Questionnaire-12 (GHQ-12) 4. Service Use and Cost Effectiveness: Modified Client Service Receipt Inventory

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026